Dual effects of 3,4-methylenedioxymethamphetamine (ecstasy) on survival and apoptosis of primary hippocampal neurons

被引:0
|
作者
Abolfazl Azami
Parichehr Pasbakhsh
Mohammad Akbari
Mohammad Barbarestani
Mohammadhosein Ghahremani
Mohammadali Shokrgozar
Ali Mandegary
Amir Kiani
Gholamreza Hassanzadeh
机构
[1] School of Pharmacy,Kermanshah University of Medical Scences
[2] Department of Anatomy,School of Medicine,Tehran University of Medical Sciences
[3] National Cell Bank of Iran,Pasteur Institute of Iran
[4] Department of Toxicology-Pharmacology,Faculty of Pharmacy,Tehran University of Medical Sciences
关键词
3,4-methylenedioxymethamphetamine; ecstasy; apoptosis; N-methyl-D-aspartate; neuronal culture;
D O I
暂无
中图分类号
R363 [病理生理学];
学科分类号
100104 ;
摘要
BACKGROUND: 3, 4-methylenedioxymethamphetamine (MDMA, also known as "ecstasy") hasbeen shown to exhibit neurotoxic effects on the hippocampus. However, exposure to sub-lethalinsults of MDMA has been reported to result in neuroprotection.OBJECTIVE: To investigate the effects of MDMA on hippocampal neuronal viability, caspase-3activity, and mRNA expression of the N-methyl-D-aspartate (NMDA) receptor 2B (NR2B) subunit.DESIGN, TIME AND SETTING: A cytological, in vitro experiment was performed at the Departmentof Anatomy, School of Medicine, and Department of Toxicology-Pharmacology, Faculty of PharmacyTehran University of Medical Sciences in 2008.MATERIALS: MDMA was extracted from ecstasy tablets, which were kindly supplied by thePharmacology-Toxicology Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran.METHODS: Hippocampal neurons were isolated from Wistar rats at gestational day 18. Followingprimary culture, hippocampal neuronal viability was detected by MTT assay. Varying concentrationsof MDMA (100 5 000 μmol/L) were used to determine lethal concentration 50 (LC50), which wasaround 1 500 μmol/L. Five concentrations of MDMA below 1 500 μmol/L (100, 200, 400, 800, and1 050 μmol/L) were used for the remaining experiments. After 24 hours of MDMA treatment,NR2B mRNA expression was detected by RT-PCR, and caspase-3 relative activity was determinedby colorimetric assay.MAIN OUTCOME MEASURES: Hippocampal neuronal viability, caspase-3 activity, andNR2B mRNA expression.RESULTS: MDMA-induced neurotoxicity in hippocampal neuronal cultures was dose-dependent. Inhigh concentrations (1 000-5 000 μmol/L) of MDMA, neuronal viability was decreased. However,with a 500 μmol/L dose of MDMA, neuronal viability was significantly increased (P < 0.01). Lowconcentrations of MDMA (200 and 400 μmol/L) significantly decreased caspase-3 activity (P < 0.01),whereas high concentrations of MDMA significantly increased caspase-3 activity (P < 0.01). NR2Bsubunit mRNA expression was not significantly altered after 100 1 050 μmol/L MDMA exposure.CONCLUSION: MDMA exhibits dual effects on hippocampal neuronal viability and caspase-3activitv. These effects are independent from NR2B subunit expression levels.
引用
收藏
页码:1068 / 1072
页数:5
相关论文
共 50 条
  • [1] Dual effects of 3, 4-methylenedioxymethamphetamine (ecstasy) on survival and apoptosis of primary hippocampal neurons
    Azami, Abolfazl
    Pasbakhsh, Parichehr
    Akbari, Mohammad
    Barbarestani, Mohammad
    Ghahremani, Mohammadhosein
    Shokrgozar, Mohammadali
    Mandegary, Ali
    Kiani, Amir
    Hassanzadeh, Gholamreza
    NEURAL REGENERATION RESEARCH, 2009, 4 (12) : 1068 - 1072
  • [2] Isotopic characterization of 3,4-methylenedioxymethamphetamine (ecstasy)
    Carter, JF
    Titterton, EL
    Sleeman, R
    FORENSIC SCIENCE INTERNATIONAL, 2003, 136 : 317 - 317
  • [3] Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression
    Jaehne, Emily J.
    Majumder, Irina
    Salem, Abdallah
    Irvine, Rodney J.
    ADDICTION BIOLOGY, 2011, 16 (01) : 7 - 19
  • [4] Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
    Allott, Kelly
    Redman, Jennifer
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (03) : 327 - 347
  • [5] 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment
    Logan, BK
    Couper, FJ
    JOURNAL OF FORENSIC SCIENCES, 2001, 46 (06) : 1426 - 1433
  • [6] Bruxism after 3,4-methylenedioxymethamphetamine (ecstasy) abuse
    Dinis-Oliveira, Ricardo Jorge
    Caldas, Ines
    Carvalho, Felix
    Magalhaes, Teresa
    CLINICAL TOXICOLOGY, 2010, 48 (08) : 863 - 864
  • [7] Multiple toxicity from 3,4-methylenedioxymethamphetamine ("Ecstasy")
    Greene, SL
    Dargan, PI
    O'Connor, N
    Jones, AL
    Kerins, M
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2003, 21 (02) : 121 - 124
  • [8] False-Positive Amphetamine/Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (CEDIA) and Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (DRI) Test Results With Fenofibrate
    Kaplan, Yusuf Cem
    Erol, Almila
    Karadas, Baris
    THERAPEUTIC DRUG MONITORING, 2012, 34 (05) : 493 - 495
  • [9] A mechanistic insight into 3,4-methylenedioxymethamphetamine ("ecstasy")-mediated hepatotoxicity
    Antolino-Lobo, Irene
    Meulenbelt, Jan
    van den Berg, Martin
    van Duursen, Majorie B. M.
    VETERINARY QUARTERLY, 2011, 31 (04) : 193 - 205
  • [10] Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
    Parrott, AC
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (01) : 71 - 83